MedPath

Great Chinasoft Technology Co.,Ltd

Ownership
-
Established
2005-03-03
Employees
28
Market Cap
-
Website
www.tianmapharma.com
Introduction

The company was founded in 1999. In July 2010, it was listed on the SME board of the Shenzhen Stock Exchange, referred to as “Huasoft Technology” for short. The company is headquartered in Suzhou, and its branches are located in Suzhou, Jiangsu, Dezhou, Shandong, Nantong, Jiangsu, Longyan, Fujian, Wuxue, Hubei, Beijing, and Cangzhou, Hebei. The company's main business is R&D, production and sales of fine chemical products. The company's products include papermaking chemicals, pharmaceutical/pesticide intermediates, fluorescent whitening agents, electronic chemicals, etc. Corporate honors: High-tech enterprise certificate; 2018 financial blockchain innovation application excellent case; Lenovo partner certificate, etc.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Clindamycin Phosphate

Product Name
克林霉素磷酸酯
Approval Number
国药准字H20044198
Approval Date
Sep 16, 2015
NMPA

Clopidogrel Bisulfate

Product Name
硫酸氢氯吡格雷
Approval Number
国药准字H20103577
Approval Date
Sep 16, 2015
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.